These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2852999)

  • 41. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance.
    Junien JL; Leonard BE
    Clin Neuropharmacol; 1989 Oct; 12(5):353-74. PubMed ID: 2558790
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of the sigma receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells.
    Rogers C; Lemaire S
    Br J Pharmacol; 1991 Aug; 103(4):1917-22. PubMed ID: 1655147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do kappa opioids mimic sigma agonists as amino acid antagonists?
    Parsons CG; Martin D; Franklin RJ; Wood JL; Headley PM
    Neuropharmacology; 1986 Feb; 25(2):217-20. PubMed ID: 3010163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. REM sleep deprivation antagonizes morphine-induced akinesia and catalepsy.
    Ukponmwan OE; v d Poel-Heisterkamp AL; Dzoljic MR
    Sleep; 1986; 9(3):415-22. PubMed ID: 3020674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.
    Sonders MS; Keana JF; Weber E
    Trends Neurosci; 1988 Jan; 11(1):37-40. PubMed ID: 2469154
    [No Abstract]   [Full Text] [Related]  

  • 46. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
    Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence for a model of activation of central sigma systems.
    Iwamoto ET
    Life Sci; 1989; 44(21):1547-54. PubMed ID: 2471910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid binding at sigma receptors: CNS and immunological implications.
    Su TP; Shukla K; Gund T
    Ciba Found Symp; 1990; 153():107-13; discussion 113-6. PubMed ID: 1963396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors.
    Takayanagi I; Koike K; Satoh M
    Gen Pharmacol; 1991; 22(5):965-7. PubMed ID: 1662176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents.
    Itzhak Y
    Mol Pharmacol; 1989 Oct; 36(4):512-7. PubMed ID: 2554109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
    Rao TS; Cler JA; Mick SJ; Dilworth VM; Contreras PC; Iyengar S; Wood PL
    Neuropharmacology; 1990 Dec; 29(12):1191-7. PubMed ID: 1963476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo.
    Iyengar S; Mick S; Dilworth V; Michel J; Rao TS; Farah JM; Wood PL
    Neuropharmacology; 1990 Mar; 29(3):299-303. PubMed ID: 2158003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.
    Carroll FI; Abraham P; Parham K; Bai X; Zhang X; Brine GA; Mascarella SW; Martin BR; May EL; Sauss C
    J Med Chem; 1992 Jul; 35(15):2812-8. PubMed ID: 1322987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ligands of opioid and sigma receptors and correction of cardiac electrical instability in post-infarction cardiosclerosis].
    Maslov LN; Lishmanov IuB; Naryzhnaia NV; Krylatov AV; Tam SV
    Eksp Klin Farmakol; 2001; 64(1):38-41. PubMed ID: 11544802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Opiate receptors].
    Latasch L; Christ R
    Anaesthesist; 1986 Feb; 35(2):55-65. PubMed ID: 2870660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leads to current therapy, to opioid receptor subtypes and to sigma receptors.
    May EL
    NIDA Res Monogr; 1992; 119():59-70. PubMed ID: 1331798
    [No Abstract]   [Full Text] [Related]  

  • 59. Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in mice.
    Kavaliers M; Ossenkopp KP
    Peptides; 1986; 7(3):449-53. PubMed ID: 3022253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.